Treatment for Uncomplicated Urinary Tract Infections

First-line Treatment Options

The European Association of Urology recommends nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days as a first-line treatment option for uncomplicated UTIs due to its minimal resistance and low propensity for collateral damage 1, 2
Fosfomycin trometamol 3 g single dose is a convenient single-dose regimen, though slightly lower efficacy than other first-line agents 1, 2
Pivmecillinam 400 mg three times daily for 3-5 days is an option, but should be avoided if early pyelonephritis is suspected 1, 3
Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days can be used if local resistance rates are <20% or if the patient hasn't used it for UTI in the previous 3 months 1, 2

Cephalosporins (e.g., cefadroxil) 500 mg twice daily for 3 days can be used as an alternative option if local E. coli resistance is <20% 1, 3
Trimethoprim 200 mg twice daily for 5 days is not recommended in the first trimester of pregnancy 1, 3

The European Association of Urology recommends trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7 days for men with uncomplicated UTIs 1, 3

Urine culture should be reserved for suspected pyelonephritis, symptoms that don't resolve or recur within 4 weeks after treatment, atypical symptoms, or pregnant women 1, 3
Selecting an appropriate antibiotic should consider local resistance patterns, patient's allergy history, recent antibiotic use, and renal function 1, 2, 3

Routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients 1, 3
For women whose symptoms don't resolve by the end of treatment or recur within 2 weeks, urine culture and antimicrobial susceptibility testing should be performed, and retreatment with a 7-day regimen using another agent should be considered 1, 3

Fluoroquinolones should be avoided for uncomplicated UTIs due to increasing resistance rates and risk of adverse effects 2
Asymptomatic bacteriuria should not be treated except in pregnant women or before urologic procedures 2
Local resistance patterns should be considered when selecting empiric therapy, particularly for trimethoprim-sulfamethoxazole 1, 2
Recurrent UTIs (≥3 UTIs/year or ≥2 UTIs in 6 months) may require different management strategies, including prophylaxis 1, 2, 4